Hormone-Refractory Prostate Cancer Completed Phase 1 Trials for Enzalutamide (DB08899)

Also known as: Hormone Refractory Prostate Cancer Disease / Hormone Refractory Prostate Cancer / Castration-resistant prostate cancer / Hormone refractory prostate cancer (disorder)

IndicationStatusPhase
DBCOND0030169 (Hormone-Refractory Prostate Cancer)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00510718A Phase 1 Study of MDV3100 in Patients With Castration-Resistant (Hormone-Refractory) Prostate CancerTreatment